{
  "title": "46: Biotech's Big Idea",
  "description": "Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "pubDate": "Wed, 04 Sep 2019 19:26:33 -0000",
  "itunes:episodeType": "full",
  "itunes:author": "Barron's",
  "itunes:subtitle": "",
  "itunes:summary": "Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "content:encoded": "<p>Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft.</p><p> </p><p>Learn more about your ad choices. Visit <a href=\"https://megaphone.fm/adchoices\">megaphone.fm/adchoices</a></p>",
  "itunes:duration": 694,
  "guid": "f8a96af8-cf49-11e9-ac18-7ff720959f96",
  "enclosure": ""
}